Hogan MJ, Pardi N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu Rev Med. 2022;73(1):17–39. https://doi.org/10.1146/annurev-med-042420-112725.
Article CAS PubMed Google Scholar
Petrone L, Sette A, de Vries RD, Goletti D. The importance of measuring SARS-CoV-2-specific T-cell responses in an ongoing pandemic. Pathogens. 2023;12(7):862. https://doi.org/10.3390/pathogens12070862.
Article CAS PubMed PubMed Central Google Scholar
Shen CF, Fu YC, Ho TS, Chen PL, Lee NY, Tsai BY, et al. Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination. Clin Immunol. 2023;251:109342. https://doi.org/10.1016/j.clim.2023.109342.
Article CAS PubMed PubMed Central Google Scholar
Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–80. https://doi.org/10.1016/j.cell.2021.01.007.
Article CAS PubMed PubMed Central Google Scholar
Primorac D, Vrdoljak K, Brlek P, Pavelić E, Molnar V, Matišić V et al. Adaptive immune responses and immunity to SARS-CoV-2. Front Immunol. 2022;13. https://doi.org/10.3389/fimmu.2022.848582
Barouch DH. COVID-19 vaccines — immunity, variants, boosters. N Engl J Med. 2022;387(11):1011–20. https://doi.org/10.1056/nejmra2206573.
Article CAS PubMed Google Scholar
Zhao Z, Kumanovics A, Love T, Melanson SEF, Meng QH, Wu AHB, et al. T cell responses correlate with self-reported disease severity and neutralizing antibody responses predict protection against SARS-CoV-2 breakthrough infection. Viruses. 2023;15(3):709. https://doi.org/10.3390/v15030709.
Article CAS PubMed PubMed Central Google Scholar
Vardhana S, Baldo L, Morice WG, Wherry EJ. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Science Immunology. 2022;7(71). https://doi.org/10.1126/sciimmunol.abo1303.
Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457–62. https://doi.org/10.1038/s41586-020-2550-z.
Article CAS PubMed Google Scholar
Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23(2):186–93. https://doi.org/10.1038/s41590-021-01122-w.
Article CAS PubMed Google Scholar
Dhawan M, Rabaan AA, Fawarah MMA, Almuthree SA, Alsubki RA, Alfaraj AH, et al. Updated Insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines. Vaccines. 2023;11(1):101. https://doi.org/10.3390/vaccines11010101.
Article CAS PubMed PubMed Central Google Scholar
Mok CKP, Chen C, Zhao S, Sun Y, Yiu K, Chan TO, et al. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study. Lancet Microbe. 2023;4(6):418–30. https://doi.org/10.1016/s2666-5247(23)00006-x.
Vardhana S, Baldo L, Morice WG 2nd, Wherry EJ. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci Immunol. 2022;7(71):eabo1303. https://doi.org/10.1126/sciimmunol.abo1303.
Article CAS PubMed PubMed Central Google Scholar
Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, Dunachie SJ, et al. T cell immune memory after COVID-19 and vaccination. BMJ Medicine. 2023;2(1):e000468. https://doi.org/10.1136/bmjmed-2022-000468.
Article PubMed PubMed Central Google Scholar
Grifoni A, Sette A. From alpha to omicron: the response of T cells. Curr Res Immunol. 2022;3:146–50. https://doi.org/10.1016/j.crimmu.2022.08.005.
Article CAS PubMed PubMed Central Google Scholar
Lu X, Yamasaki S. Current understanding of T cell immunity against SARS-CoV-2. Inflammation and Regeneration. 2022;42(1). https://doi.org/10.1186/s41232-022-00242-6
Tan AT, Lim JME, Le Bert N, Kunasegaran K, Chia A, Qui MDC et al. Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals. Journal of Clinical Investigation. 2021;131(17). https://doi.org/10.1172/jci152379
Lopez-Gomez A, Pelaez-Prestel HF, Juarez I. Approaches to evaluate the specific immune responses to SARS-CoV-2. Vaccine. 2023;41(43):6434–43. https://doi.org/10.1016/j.vaccine.2023.09.033.
Article CAS PubMed Google Scholar
Dourdouna MM, Tatsi EB, Syriopoulou V, Michos A. Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity. Diagn Microbiol Infect Dis. 2023;106(3):115948. https://doi.org/10.1016/j.diagmicrobio.2023.115948.
Article CAS PubMed PubMed Central Google Scholar
Schwarz M, Mzoughi S, Lozano-Ojalvo D, Tan AT, Bertoletti A, Guccione E. T cell immunity is key to the pandemic endgame: How to measure and monitor it. Curr Res Immunol. 2022;3:215–21. https://doi.org/10.1016/j.crimmu.2022.08.004.
Article CAS PubMed PubMed Central Google Scholar
Jaganathan S, Stieber F, Rao SN, Nikolayevskyy V, Manissero D, Allen N, et al. Preliminary evaluation of QuantiFERON SARS-CoV-2 and QIAreach anti-SARS-CoV-2 total test in recently vaccinated individuals. Infect Dis Ther. 2021;10(4):2765–76. https://doi.org/10.1007/s40121-021-00521-8.
Article PubMed PubMed Central Google Scholar
Ameratunga R, Woon ST, Jordan A, Longhurst H, Leung E, Steele R, et al. Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection. Expert Rev Clin Immunol. 2021;17(5):421–30. https://doi.org/10.1080/1744666x.2021.1905525.
Article CAS PubMed Google Scholar
Kim SH. Interferon-γ release assay for cytomegalovirus (IGRA-CMV) for risk stratification of posttransplant CMV infection: is it time to apply IGRA-CMV in routine clinical practice? Clin Infect Dis. 2020;71(9):2386–8. https://doi.org/10.1093/cid/ciz1211.
Article CAS PubMed Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Article PubMed PubMed Central Google Scholar
Dourdouna M-M, Kourlaba G, Michos A. Use of QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with 2 or 3 doses of mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis. PROSPERO. 2023;73(1):17.
QIAGEN. QuantiFERON SARS-CoV-2. https://www.qiagen.com/gb/products/diagnostics-and-clinical-research/infectious-disease/quantiferon-sars-cov-2?catno=626420
Stieber F, Allen N, Carpenter K, Hu P, Alagna R, Rao S, et al. Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay. Pulmonology. 2023;29(2):151–3. https://doi.org/10.1016/j.pulmoe.2022.09.006.
Article CAS PubMed Google Scholar
QIAGEN. QuantiFERON SARS-CoV-2 ELISA kit instructions for use. 2022;7-8, 27–9
Critical Appraisal Skills Programme CASP checklists. https://casp-uk.net/casp-tools-checklists/. Accessed April 22 2024
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. https://doi.org/10.1136/bmj.327.7414.557.
Article PubMed PubMed Central Google Scholar
Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023
Furuya-Kanamori L, Barendregt JJ. SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195–203. https://doi.org/10.1097/xeb.0000000000000141.
Furuya-Kanamori L, Doi SA. LFK: Stata module to compute LFK index and plot for detection of publication bias in meta-analysis. 2021
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:n71. https://doi.org/10.1136/bmj.n71.
Arias-Cabrales C, Folgueiras M, Faura A, Eguia J, Padilla E, Hurtado S, et al. Dynamics of humoral and cellular responses in renal transplant recipients receiving 3 doses of SARS-CoV-2 mRNA vaccine. Transplantation. 2023;107(2):457–65. https://doi.org/10.1097/tp.0000000000004433.
留言 (0)